RILONACEPT (IL-1 TRAP) DEMONSTRATES IMPROVEMENT IN HEALTH-RELATED OUTCOME MEASURES IN SUBJECTS WITH CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS) IN A PLACEBO-CONTROLLED TRIAL by ProQuest

VIEWS: 10 PAGES: 2

More Info
To top